Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma
Rebecca C Abbott(The University of Melbourne), Misty R. Jenkins(The University of Melbourne)
Cited by 43
Related Papers
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma
|Neuro-Oncology Advances|2023|26